🚀 VC round data is live in beta, check it out!
MedCap Valuation Multiples
Discover revenue and EBITDA valuation multiples for MedCap and similar public comparables like PHC Holdings, QuidelOrtho, Integra Lifesciences, CeriBell and more.
MedCap Overview
About MedCap
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
Founded
2001
HQ
Employees
270
Website
Sectors
Financials (LTM)
EV
$858M
MedCap Financials
MedCap reported last 12-month revenue of $240M and EBITDA of $52M.
In the same LTM period, MedCap generated $140M in gross profit, $52M in EBITDA, and $26M in net income.
Revenue (LTM)
MedCap P&L
In the most recent fiscal year, MedCap reported revenue of $234M and EBITDA of $52M.
MedCap expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $240M | XXX | $234M | XXX | XXX | XXX |
| Gross Profit | $140M | XXX | $135M | XXX | XXX | XXX |
| Gross Margin | 58% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $52M | XXX | $52M | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 22% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $26M | XXX | $24M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MedCap Stock Performance
MedCap has current market cap of $846M, and enterprise value of $858M.
Market Cap Evolution
MedCap's stock price is $56.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $858M | $846M | 0.3% | XXX | XXX | XXX | $1.62 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedCap Valuation Multiples
MedCap trades at 3.6x EV/Revenue multiple, and 16.4x EV/EBITDA.
EV / Revenue (LTM)
MedCap Financial Valuation Multiples
As of April 20, 2026, MedCap has market cap of $846M and EV of $858M.
Equity research analysts estimate MedCap's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MedCap has a P/E ratio of 32.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $846M | XXX | $846M | XXX | XXX | XXX |
| EV (current) | $858M | XXX | $858M | XXX | XXX | XXX |
| EV/Revenue | 3.6x | XXX | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | 16.4x | XXX | 16.6x | XXX | XXX | XXX |
| EV/EBIT | 24.4x | XXX | 25.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.1x | XXX | 6.4x | XXX | XXX | XXX |
| P/E | 32.4x | XXX | 34.7x | XXX | XXX | XXX |
| EV/FCF | 273.0x | XXX | 28.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MedCap Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MedCap Margins & Growth Rates
MedCap's revenue in the last 12 month grew by 8%.
MedCap's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.4M for the same period.
MedCap's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MedCap's rule of X is 48% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
MedCap Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 22% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 44% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MedCap Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| MedCap | XXX | XXX | XXX | XXX | XXX | XXX |
| PHC Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| QuidelOrtho | XXX | XXX | XXX | XXX | XXX | XXX |
| Integra Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| CeriBell | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanosonics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedCap M&A Activity
MedCap acquired XXX companies to date.
Last acquisition by MedCap was on XXXXXXXX, XXXXX. MedCap acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MedCap
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedCap Investment Activity
MedCap invested in XXX companies to date.
MedCap made its latest investment on XXXXXXXX, XXXXX. MedCap invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MedCap
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MedCap
| When was MedCap founded? | MedCap was founded in 2001. |
| Where is MedCap headquartered? | MedCap is headquartered in Sweden. |
| How many employees does MedCap have? | As of today, MedCap has over 270 employees. |
| Who is the CEO of MedCap? | MedCap's CEO is Anders Dahlberg. |
| Is MedCap publicly listed? | Yes, MedCap is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of MedCap? | MedCap trades under MCAP ticker. |
| When did MedCap go public? | MedCap went public in 2004. |
| Who are competitors of MedCap? | MedCap main competitors are PHC Holdings, QuidelOrtho, Integra Lifesciences, CeriBell. |
| What is the current market cap of MedCap? | MedCap's current market cap is $846M. |
| What is the current revenue of MedCap? | MedCap's last 12 months revenue is $240M. |
| What is the current revenue growth of MedCap? | MedCap revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of MedCap? | Current revenue multiple of MedCap is 3.6x. |
| Is MedCap profitable? | Yes, MedCap is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MedCap? | MedCap's last 12 months EBITDA is $52M. |
| What is MedCap's EBITDA margin? | MedCap's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of MedCap? | Current EBITDA multiple of MedCap is 16.4x. |
| What is the current FCF of MedCap? | MedCap's last 12 months FCF is $3M. |
| What is MedCap's FCF margin? | MedCap's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of MedCap? | Current FCF multiple of MedCap is 273.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.